WALTHAM, Mass.--(BUSINESS WIRE)--Oscient Pharmaceuticals Corporation (Nasdaq: OSCI) will participate in the Rodman & Renshaw 10th Annual Healthcare Conference on Tuesday, November 11, 2008 in New York City. The Company’s President and CEO, Steven Rauscher, will provide an overview of the Company; highlight details on the recent market performance of ANTARA® (fenofibrate) capsules and FACTIVE® (gemifloxacin mesylate) tablets; and discuss the Company’s recently announced results for the third quarter of 2008, in which Oscient recorded $21.8 million in revenues.
